{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:16:21Z","timestamp":1788142581473,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of Science and Technology Department of Sichuan Province","award":["2024YFHZ0358"],"award-info":[{"award-number":["2024YFHZ0358"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08438-x","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:09:55Z","timestamp":1781784595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE\/H2S-linked vascular and immune reprogramming"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuxin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"4","key":"8438_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, Sun L, Liu Y, Du Y, Guo X, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78(4):770\u201382.","journal-title":"J Hepatol"},{"key":"8438_CR2","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.2147\/CMAR.S537930","volume":"17","author":"W Li","year":"2025","unstructured":"Li W, Li GC, Luo CS, Yu QF, Cui M. Angiogenesis and Immunosuppressive Niche in Hepatocellular Carcinoma: Reshaping Vascular - Immune Axis to Potentiate antiPD\u2009\u2013\u20091\/PD - L1 Therapy. Cancer Manage Res. 2025;17:2245\u201359.","journal-title":"Cancer Manage Res"},{"issue":"4","key":"8438_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.trecan.2018.02.010","volume":"4","author":"T Stylianopoulos","year":"2018","unstructured":"Stylianopoulos T, Munn LL, Jain RK. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy. Trends cancer. 2018;4(4):258\u20139.","journal-title":"Trends cancer"},{"issue":"7","key":"8438_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bjc.6604965","volume":"100","author":"C Alfaro","year":"2009","unstructured":"Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, Palazon A, Hervas-Stubbs S, Gurpide A, Lopez-Picazo JM, et al. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer. 2009;100(7):1111\u20139.","journal-title":"Br J Cancer"},{"issue":"3","key":"8438_CR5","first-page":"881","volume":"29","author":"J Wada","year":"2009","unstructured":"Wada J, Suzuki H, Fuchino R, Yamasaki A, Nagai S, Yanai K, Koga K, Nakamura M, Tanaka M, Morisaki T, et al. The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions. Anticancer Res. 2009;29(3):881\u20138.","journal-title":"Anticancer Res"},{"issue":"Pt 4","key":"8438_CR6","doi-asserted-by":"publisher","first-page":"136580","DOI":"10.1016\/j.ijbiomac.2024.136580","volume":"281","author":"X Lu","year":"2024","unstructured":"Lu X, Li L, Lin J, Wu X, Li W, Tan C, Huang J, Pu J. PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein. Int J Biol Macromol. 2024;281(Pt 4):136580.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"8438_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40164-023-00378-2","volume":"12","author":"ZQ Chen","year":"2023","unstructured":"Chen ZQ, Zuo XL, Cai J, Zhang Y, Han GY, Zhang L, Ding WZ, Wu JD, Wang XH. Hypoxia-associated circPRDM4 promotes immune escape via HIF-1\u03b1 regulation of PD-L1 in hepatocellular carcinoma. Experimental Hematol Oncol. 2023;12(1):17.","journal-title":"Experimental Hematol Oncol"},{"issue":"1","key":"8438_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41419-025-07444-z","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Liu Y, Zhao J, Wang G, Chen H, Tang Y, Ouyang D, Xie S, You J, et al. Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-\u03baB and STAT3 signaling pathways in nasopharyngeal carcinoma. Cell Death Dis. 2025;16(1):129.","journal-title":"Cell Death Dis"},{"key":"8438_CR9","doi-asserted-by":"publisher","first-page":"105119","DOI":"10.1016\/j.phrs.2020.105119","volume":"161","author":"N Dilek","year":"2020","unstructured":"Dilek N, Papapetropoulos A, Toliver-Kinsky T, Szabo C. Hydrogen sulfide: An endogenous regulator of the immune system. Pharmacol Res. 2020;161:105119.","journal-title":"Pharmacol Res"},{"issue":"4","key":"8438_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1158\/0008-5472.CAN-22-1837","volume":"83","author":"T Yue","year":"2023","unstructured":"Yue T, Li J, Zhu J, Zuo S, Wang X, Liu Y, Liu J, Liu X, Wang P, Chen S. Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer. Cancer Res. 2023;83(4):595\u2013612.","journal-title":"Cancer Res"},{"issue":"1","key":"8438_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-019-1083-5","volume":"38","author":"D Yang","year":"2019","unstructured":"Yang D, Li T, Li Y, Zhang S, Li W, Liang H, Xing Z, Du L, He J, Kuang C, et al. H(2)S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma. J experimental Clin cancer research: CR. 2019;38(1):88.","journal-title":"J experimental Clin cancer research: CR"},{"key":"8438_CR12","doi-asserted-by":"crossref","unstructured":"Khattak S, Rauf MA, Khan NH, Zhang QQ, Chen HJ, Muhammad P, Ansari MA, Alomary MN, Jahangir M, Zhang CY et al. Hydrogen sulfide biology and its role in cancer. Molecules(Basel, Switzerland). 2022;27(11).","DOI":"10.3390\/molecules27113389"},{"key":"8438_CR13","doi-asserted-by":"publisher","first-page":"109564","DOI":"10.1016\/j.intimp.2022.109564","volume":"115","author":"T Zhou","year":"2023","unstructured":"Zhou T, Liu W, Lai H, Liu Y, Su W, Xu Z. Hydrogen Sulfide Promotes Osteogenesis by Modulating Macrophage Polarization. Int Immunopharmacol. 2023;115:109564.","journal-title":"Int Immunopharmacol"},{"key":"8438_CR14","doi-asserted-by":"publisher","first-page":"111990","DOI":"10.1016\/j.intimp.2024.111990","volume":"132","author":"Z He","year":"2024","unstructured":"He Z, Zhu Y, Ma H, Shen Q, Chen X, Wang X, Shao H, Wang Y, Yang S. Hydrogen sulfide regulates macrophage polarization and necroptosis to accelerate diabetic skin wound healing. Int Immunopharmacol. 2024;132:111990.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"8438_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s10020-025-01186-6","volume":"31","author":"W Cai","year":"2025","unstructured":"Cai W, Wu A, Lin Z, Cao W, Pathak JL, Jaspers RT, Li R, Li X, Zheng K, Lin Y, et al. S-propargyl-cysteine attenuates temporomandibular joint osteoarthritis by regulating macrophage polarization via Inhibition of JAK\/STAT signaling. Mol Med (Cambridge Mass). 2025;31(1):128.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"10","key":"8438_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1089\/ars.2009.2899","volume":"12","author":"M Whiteman","year":"2010","unstructured":"Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal. 2010;12(10):1147\u201354.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"8438_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2010.09.001","volume":"25","author":"QH Gong","year":"2011","unstructured":"Gong QH, Wang Q, Pan LL, Liu XH, Xin H, Zhu YZ. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-\u03baB pathway in rats. Brain Behav Immun. 2011;25(1):110\u20139.","journal-title":"Brain Behav Immun"},{"key":"8438_CR18","doi-asserted-by":"publisher","first-page":"115717","DOI":"10.1016\/j.addr.2025.115717","volume":"227","author":"N Yang","year":"2025","unstructured":"Yang N, Cai Y, Sun S, Nie J, Gong F, Pei Z, Cheng L. Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigms. Adv Drug Deliv Rev. 2025;227:115717.","journal-title":"Adv Drug Deliv Rev"},{"key":"8438_CR19","doi-asserted-by":"publisher","first-page":"1291170","DOI":"10.3389\/fcell.2023.1291170","volume":"11","author":"L Ping","year":"2023","unstructured":"Ping L, Zhi-Ming L, Bi-Shan Z, Lei Z, Bo Y, Yi-Chun Z, Ming-Jie W. S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype. Front cell Dev biology. 2023;11:1291170.","journal-title":"Front cell Dev biology"},{"key":"8438_CR20","doi-asserted-by":"crossref","unstructured":"Xi H, Wang C, Li Q, Ye Q, Zhu Y, Mao Y. S-Propargyl-cysteine ameliorates peripheral nerve injury through microvascular reconstruction. Antioxid (Basel Switzerland) 2023; 12(2).","DOI":"10.3390\/antiox12020294"},{"issue":"12","key":"8438_CR21","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/s41418-025-01533-4","volume":"32","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yu R, Li S, Yuan M, Hu T, Liu J, Ke H, Ye S, Yun J, Huang J, et al. KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression. Cell Death Differ. 2025;32(12):2225\u201338.","journal-title":"Cell Death Differ"},{"key":"8438_CR22","doi-asserted-by":"publisher","first-page":"114579","DOI":"10.1016\/j.intimp.2025.114579","volume":"155","author":"J Liu","year":"2025","unstructured":"Liu J, Su Y, Zhang C, Dong H, Yu R, Yang X, Tian Y, Feng Y, Zhang J, Shi M, et al. NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90\u03b1\/EZH2\/CXCL9 axis in colon cancer. Int Immunopharmacol. 2025;155:114579.","journal-title":"Int Immunopharmacol"},{"issue":"30","key":"8438_CR23","first-page":"e00461","volume":"12","author":"M Yuan","year":"2025","unstructured":"Yuan M, Chen S, Lin Z, Yu R, Chao K, Ye S, Li Q, Ke H, Zhang C, Huang J, et al. ACSS2-Mediated Histone H4 Lysine 12 Crotonylation (H4K12cr) Alleviates Colitis via Enhancing Transcription of CLDN7. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2025;12(30):e00461.","journal-title":"Baden-Wurttemberg Germany)"},{"issue":"6","key":"8438_CR24","doi-asserted-by":"publisher","first-page":"e20525","DOI":"10.1371\/journal.pone.0020525","volume":"6","author":"K Ma","year":"2011","unstructured":"Ma K, Liu Y, Zhu Q, Liu CH, Duan JL, Tan BK, Zhu YZ. H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS ONE. 2011;6(6):e20525.","journal-title":"PLoS ONE"},{"issue":"20","key":"8438_CR25","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1016\/j.molcel.2024.08.035","volume":"84","author":"H Zheng","year":"2024","unstructured":"Zheng H, Chen H, Cai Y, Shen M, Li X, Han Y, Deng X, Cao H, Liu J, Li H, et al. Hydrogen sulfide-mediated persulfidation regulates homocysteine metabolism and enhances ferroptosis in non-small cell lung cancer. Mol Cell. 2024;84(20):4016\u2013e40304016.","journal-title":"Mol Cell"},{"issue":"9","key":"8438_CR26","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s42255-023-00862-3","volume":"5","author":"E Joulia","year":"2023","unstructured":"Joulia E, Metallo CM. Methionine and H(2)S alter cancer-immune dialogue. Nat metabolism. 2023;5(9):1456\u20138.","journal-title":"Nat metabolism"},{"issue":"6","key":"8438_CR27","doi-asserted-by":"publisher","first-page":"e21077","DOI":"10.1371\/journal.pone.0021077","volume":"6","author":"ZW Lee","year":"2011","unstructured":"Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, Deng LW. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE. 2011;6(6):e21077.","journal-title":"PLoS ONE"},{"issue":"6835","key":"8438_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342\u20138.","journal-title":"Nature"},{"key":"8438_CR29","doi-asserted-by":"crossref","unstructured":"Zerdes I, Wallerius M, Sifakis EG, Wallmann T, Betts S, Bartish M, Tsesmetzis N, Tobin NP, Coucoravas C, Bergh J et al. STAT3 activity promotes programmed death-ligand 1 expression and suppresses immune responses in breast cancer. Cancers 2019; 11(10).","DOI":"10.3390\/cancers11101479"},{"issue":"9","key":"8438_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0022034517712435","volume":"96","author":"LL Bu","year":"2017","unstructured":"Bu LL, Yu GT, Wu L, Mao L, Deng WW, Liu JF, Kulkarni AB, Zhang WF, Zhang L, Sun ZJ. STAT3 Induces Immunosuppression by Upregulating PD-1\/PD-L1 in HNSCC. J Dent Res. 2017;96(9):1027\u201334.","journal-title":"J Dent Res"},{"issue":"1","key":"8438_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"8438_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21(1):159\u201368.","journal-title":"Cell Res"},{"issue":"5","key":"8438_CR33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/ars.2013.5308","volume":"20","author":"K Kashfi","year":"2014","unstructured":"Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal. 2014;20(5):831\u201346.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"8438_CR34","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1038\/s41467-020-20089-0","volume":"11","author":"YZ Zhang","year":"2020","unstructured":"Zhang YZ, Yuan J, Zhang L, Chen C, Wang Y, Zhang G, Peng L, Xie SS, Jiang J, Zhu JK, et al. Coupling of H3K27me3 recognition with transcriptional repression through the BAH-PHD-CPL2 complex in Arabidopsis. Nat Commun. 2020;11(1):6212.","journal-title":"Nat Commun"},{"issue":"20","key":"8438_CR35","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"3","key":"8438_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, Kogadeeva M, Picotti P, Meissner F, Mann M, et al. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell. 2016;167(3):829\u2013e842813.","journal-title":"Cell"},{"issue":"3","key":"8438_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcb.2017.10.010","volume":"28","author":"K Rohlenova","year":"2018","unstructured":"Rohlenova K, Veys K, Miranda-Santos I, De Bock K, Carmeliet P. Endothelial Cell Metabolism in Health and Disease. Trends Cell Biol. 2018;28(3):224\u201336.","journal-title":"Trends Cell Biol"},{"key":"8438_CR38","doi-asserted-by":"publisher","first-page":"155747","DOI":"10.1016\/j.metabol.2023.155747","volume":"151","author":"R Shah","year":"2024","unstructured":"Shah R, Ibis B, Kashyap M, Boussiotis VA. The role of ROS in tumor infiltrating immune cells and cancer immunotherapy. Metab Clin Exp. 2024;151:155747.","journal-title":"Metab Clin Exp"},{"issue":"6","key":"8438_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/sji.12350","volume":"82","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya S, Saha J. Tumour, Oxidative Stress and Host T Cell Response: Cementing the Dominance. Scand J Immunol. 2015;82(6):477\u201388.","journal-title":"Scand J Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08438-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:40:37Z","timestamp":1788140437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08438-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8438"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08438-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Ethics Committee of Sichuan Cancer Hospital (KY-2025-020). All animal experiments were conducted in accordance with institutional guidelines for the care and use of laboratory animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1117"}}